Compile Data Set for Download or QSAR
Report error Found 57 Enz. Inhib. hit(s) with all data for entry = 9401
TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464030(WX013 | US10787435, Example 013)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464027(WX011 | US10787435, Example 011)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464019(WX008 | US10787435, Example 008)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464021(WX009 | US10787435, Example 009)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464016(WX006 | US10787435, Example 006)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464017(WX007 | US10787435, Example 007)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464011(WX004 | US10787435, Example 004)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464015(WX005 | US10787435, Example 005)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM463999(WX002 | US10787435, Example 002 | US11117891, Exam...)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464009(WX003 | US10787435, Example 003)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM463987(WX001 | US10787435, Example 001)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464053(WX030 | US10787435, Example 031)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464054(WX031 | US10787435, Example 032)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464044(US10787435, Example 030 | WX021 | US10787435, Exam...)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464049(WX026 | US10787435, Example 026)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464047(WX024 | US10787435, Example 024)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464048(WX025 | US10787435, Example 025)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464045(WX022 | US10787435, Example 022)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464046(WX023 | US10787435, Example 023)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464044(US10787435, Example 030 | WX021 | US10787435, Exam...)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464040(WX018 | US10787435, Example 018)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464042(WX019 | US10787435, Example 019)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464069(WX046 | US10787435, Example 047)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464067(WX044 | US10787435, Example 045)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464068(WX045 | US10787435, Example 046)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464066(WX043 | US10787435, Example 044)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464063(WX040 | US10787435, Example 041)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464061(WX038 | US10787435, Example 039)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464062(WX039 | US10787435, Example 040)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464059(WX036 | US10787435, Example 038)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464060(WX037 | US10787435, Example 037)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464057(WX034 | US10787435, Example 035)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464058(WX035 | US10787435, Example 036)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464055(WX032 | US10787435, Example 033)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464056(WX033 | US10787435, Example 034)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464079(WX056 | US10787435, Example 057)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464080(WX057 | US10787435, Example 058)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464077(WX054 | US10787435, Example 055)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464078(WX055 | US10787435, Example 056)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464075(WX052 | US10787435, Example 053)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464076(WX053 | US10787435, Example 054)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464073(WX050 | US10787435, Example 051)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464074(WX051 | US10787435, Example 052)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464072(WX049 | US10787435, Example 050)
Affinity DataIC50: 50nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464031(WX014 | US10787435, Example 014)
Affinity DataIC50: 525nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464070(WX047 | US10787435, Example 048)
Affinity DataIC50: 525nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464024(WX010 | US10787435, Example 010)
Affinity DataIC50: 525nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464050(WX027 | US10787435, Example 028)
Affinity DataIC50: 525nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464036(WX016 | US10787435, Example 016)
Affinity DataIC50: 525nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Fuijan Cosunter Pharmaceutical

US Patent
LigandPNGBDBM464071(WX048 | US10787435, Example 049)
Affinity DataIC50: 525nMAssay Description:Reagents:Base Reaction Buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSOCompound T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2021
Entry Details
US Patent

Displayed 1 to 50 (of 57 total ) | Next | Last >>
Jump to: